Company Profiles

driven by the PitchBook Platform

Verax Biomedical

Description

Developer of rapid tests intended for the detection of bacterial contaminants in blood cells and tissue. The company's platelet PGD (Pan Genera Detection) test, a rapid test for the detection of bacterial contamination in platelets, enable the blood banks to detect blood contamination while blood transfusions and transplants.

1999

Founded

PRIVATE

Status

11-50

Employees

Series AA

Latest Deal Type

$12.6M

Latest Deal Amount

$58.7M

Total Amount Raised

Description

Developer of rapid tests intended for the detection of bacterial contaminants in blood cells and tissue. The company's platelet PGD (Pan Genera Detection) test, a rapid test for the detection of bacterial contamination in platelets, enable the blood banks to detect blood contamination while blood transfusions and transplants.

Website:

www.veraxbiomedical.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Primary Office

148 Bartlett Street Marlborough, MA 01752United States +1 (866) 948-3729
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Verax Biomedical's full profile, request a free trial.

    Verax Biomedical Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Verax Biomedical Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Verax Biomedical Investors (10)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BioVentures InvestorsVenture CapitalMinority000 0000000 0000
    Clark EnterprisesReal EstateMinority000 0000000 0000
    CNF InvestmentsPE/BuyoutMinority000 0000000 0000
    Collaborative Seed & Growth PartnersVenture CapitalMinority000 0000000 0000
    KB PartnersAngel GroupMinority000 0000000 0000
    BioVentures Investors Venture Capital
    Clark Enterprises Real Estate
    CNF Investments PE/Buyout
    Collaborative Seed & Growth Partners Venture Capital
    KB Partners Angel Group

    Verax Biomedical Executive Team (9)

    NameTitleBoard
    Seat
    Contact
    Info
    James Lousararian JDChief Executive Officer
    Joe SandersCo-Founder, Senior Vice President of Marketing and Business Development
    Joe StraightCo-Founder
    Paul Mintz MDChief Medical Officer and Senior Vice President
    R.Scott McKenzieSenior Vice President of Operations
    James Lousararian JD Chief Executive Officer
    Joe Sanders Co-Founder, Senior Vice President of Marketing and Business Development
    Joe Straight Co-Founder
    Paul Mintz MD Chief Medical Officer and Senior Vice President
    R.Scott McKenzie Senior Vice President of Operations

    Verax Biomedical Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Buzz BensonSightLine PartnersFounder & Managing Director000 0000
    James Koziarz Ph.DSelfBoard Member000 0000
    Joseph Del GuercioClark EnterprisesSenior Vice President, Clark Enterprises & Managing Director, CNF Investments000 0000
    Marc Goldberg JDBioVentures InvestorsCo-Founder & General Partner000 0000
    Robert ZieserlSelfAngel (individual)000 0000
    Buzz Benson Founder & Managing Director SightLine Partners
    James Koziarz Ph.D Board Member Self
    Joseph Del Guercio Senior Vice President, Clark Enterprises & Managing Director, CNF Investments Clark Enterprises
    Marc Goldberg JD Co-Founder & General Partner BioVentures Investors
    Robert Zieserl Angel (individual) Self
    Request full access to PitchBook